How Do I Treat My Vitiligo?

HOW DO I TREAT MY VITILIGO?

References

1.  Forschner T, Buchholt S, Stockfleth E. “Current State of Vitiligo Therapy – Evidence-Based Analysis of the Literature.” Journal of German Dermatology. 2007; 5(6):467-475.

2.  Groysman V, Sami N. “Vitiligo.” eMedicine Dermatology. emedicine.emedscape.com. November 30, 2009.

3.  Gawkrodger D.W., Ormerod A.D., Shaw L, Mauri-Sole I, Whitton M.E. , Watts J, Anstey A.V., Ingham J, Young K. “Guideline for the Diagnosis and Management of Vitiligo.” The British Journal of Dermatology. 2008;159(5):1051-1076.

4.  Kovacs S. Vitiligo. Journal of the American Academy of Dermatology. 1998;38(5):646-668.

5.  Mahmoud B, Hexsel C, Hamzavi I. “An Update on New and Emerging Options for the Treatment of Vitiligo.” Skin Therapy Letter. 2008;13(2):1-6.

6.  Arroyo M, Tift L. “Vitiligo Therapy: Where Are We Now?” Journal of Drugs in Dermatology. 2003;2(4):404-408.

7.  Whitton M, Ashcroft D, Gonzalez U. “Therapeutic Interventions for Vitiligo.” Journal of the American Academy of Dermatology. 2008; 59(4):713-717.

8.  Chimento S, Newland M, Ricotti C, Nistico S, Romanelli P. “A Pilot Study to Determine the Safety and Efficacy of Monochromatic Excimer Light in the Treatment of Vitiligo.” Journal of Drugs in Dermatology. 2008; 7(3):258-263.

9.  Mayoral F, Vega J, Stavisky H, McCormick C, Parneix-Spake Anne. “Retrospective Analysis of Pimecrolimus Cream 1% for Treatment of Facial Vitiligo.” Journal of Drugs in Dermatology. 2007; 6(5): 517-521.

10.  Majid I. “Does Topical Tacrolimus Ointment Enhance the Efficacy of Narrowband Ultraviolet Therapy in Vitiligo? A Left-Right Comparison Study.” Photodermatology, Photoimmunology, Photomedicine. 2010;26(5):230-4.

11.  Silverberg N, Lin P, Travis L, Farley-Li J, Mancini A, Wagner A, Chamlin S, and Paller A. “Tacrolimus Ointment Promotes Repigmentation of Vitiligo in Children: A Review of 57 Cases.” Journal of the American Academy of Dermatology. 2004; 51(5):760-766.

12.  Berti S, Buggiani G, Lotti T. “Use of Tacrolimus Ointment in Vitiligo Alone or in Combination Therapy.” Skin Therapy Letter. 2009;19(4).

13.  Travis L, Weinberg J, Silverberg N. “Successful Treatment of Vitiligo with 0.1% Tacrolimus Ointment.” Archives of Dermatology. 2003;139:571-574.

14.  Hossari-Madan A, Halder R. “Topical Treatment and Combination Approaches for Vitiligo: New Insights, New Developments.” Journal of Italian Dermatology and Venereology. 2010;145(1):57-78. Kwinter J,Pelletier J, Khambalia A, Pope B. “High-Potency Steroid Use in Children with Vitiligo: A Retrospective Study.” Journal of the American Academy of Dermatology. 2007;56(2):236-241.

15.  LB Travis, Nanette B. Silverberg. “Calcipotriene and Corticosteroid Combination Therapy for Vitiligo.” Pediatric Dermatology. 2004;21(4):495-8.

16.  Laurie Barclay. “Use of Topical Corticosteroids for Dermatologic Conditions Reviewed.” Medscape Medical News. January 21, 2009. www.Medscape.com.

17.  D.J. Gawkrodger. “Pseudocatalase and narrowband ultraviolet B for vitiligo: clearing the picture.” British Journal of Dermatology. Vol. 161, Issue 4. Pages 721-722. October 2009.

18.  Norra MacReady. “Tar Product Tackles Hypopigmentation Quickly.” Skin & Allergy News. March 2002, Vol. 35, No. 3.

19.  Ulrich R. Hengee, Thomas Ruzicka, Robert A. Schwartz and Michael J. Cork. “Adverse Effects of Topical Glucocorticosteroids.” Journal of the American Academy of Dermatology. January 2006. Vol. 54. No. 1. 3-15.